Gurses Rabia Ozden

Affiliations

  • Chief Medical Officer at Ocular Therapeutix Inc (OCUL), 2024-02-06
  • Director at Adverum Biotechnologies Inc. (ADVM), 2023-06-13
  • Chief Development Officer at Akouos Inc. (AKUS), 2020-06-25
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
OCUL $4.86 6,346 Officer 153,054 2024-02-05 Filing
OCUL $4.95 7,764 Officer 92,767 2024-01-31 Filing
OCUL $4.93 832 Officer 100,531 2023-07-07 Filing
OCUL $4.24 6,416 Officer 101,363 2023-02-06 Filing